Risk-taking behavior identified by the BART decreases after acclimatization. by Erica C. Heinrich (6832055)

ROC curves of NMM for CN-to-MCI and MCI-to-AD conversion in five-year time horizon. by Batuhan K. Karaman (14129223)

Subjects:

Δ ROC AUC values obtained with NMM by the addition of various biomarker combinations to the clinical data (participant demographics, clinical assessments, and cognitive assessments... by Batuhan K. Karaman (14129223)

Subjects:

The number of available subjects in each diagnostic group for annual follow-up visits. by Batuhan K. Karaman (14129223)

Subjects:

Feed-forward, fully-connected neural network architecture. by Batuhan K. Karaman (14129223)

Subjects:

Summary statistics of the participants at baseline. by Batuhan K. Karaman (14129223)

Subjects:

The degree of missingness (%) in different baseline data modalities for two patient groups. by Batuhan K. Karaman (14129223)

Subjects:

Mendelian randomization results with COVID-19. by Alish B. Palmos (5857379)

“…Using genetic instruments and under the assumptions of Mendelian randomization, the top section shows results consistent with six blood markers being significantly causally associated with an increased risk of hospitalization as a result of COVID-19 and the nine blood markers causally associated with a decreased risk of hospitalization, as well as one protein showing a decrease in risk of hospitalization. …”

Plots of observed minus predicted probability of number of U5 deaths for six models. by Alemayehu Siffir Argawu (17373545)

Subjects:

Blood markers putatively causally associated with hospitalized COVID-19. by Alish B. Palmos (5857379)

“…Using genetic instruments and under the assumptions of Mendelian randomization, six blood markers were causally associated with a significantly increased risk for hospitalization COVID-19 and nine blood markers were causally associated with a significantly decreased risk for hospitalization (q_FDR ≤ 0.05). …”

Blood markers putatively causally associated with need for respiratory support/death due to COVID-19. by Alish B. Palmos (5857379)

“…Using genetic instruments and under the assumptions of Mendelian randomization, five blood markers were causally associated with a significantly increased risk for need for respiratory support/death due to COVID-19 and eight blood markers were causally associated with a significantly decreased risk for respiratory support/death (q_FDR ≤ 0.05). …”

Predicting pCR/non-pCR by combining ctDNA and mrTRG information. by Yaqi Wang (1555240)

Subjects:

Multivariate regression analysis to explain the decrease in visibility and palpability. by Miharu Matsumoto (21304390)

Significant interaction (time by group) for PPTd. by Einat Kodesh (13132997)

Optimized model outperforms Oncotype DX risk scores for prognostic prediction. by Kevin Yao (11921356)

Risk of fracture with competing risk in denosumab users versus non-users. by Arisa Kobayashi (4379608)

Subjects:

Significant decrease of the coiled-coil score in the double proline-substituted CAHS3 mutant. by Akihiro Tanaka (342394)

Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated. by Sebastian Cremer (11592273)

Subjects:

ACEi or ARB do not affect expression of ACE2 in lung epithelial cells. by Sebastian Cremer (11592273)

Subjects:

Baseline characteristics of patients in the uncomplicated phase of COVID-19. by Sebastian Cremer (11592273)

Subjects: